BQ-788 29A both po and iv application

both po and iv application routes show a rapid drop below 200 ng/mL (~0

If approved by the United States FDA

CHR-2797 (6 μM) treatment leads to the up-regulation of genes involved in amino acid transport and metabolic pathways

InChiKey: LQBVNQSMGBZMKD-UHFFFAOYSA-N

Compound 401 is reported to be a poor inhibitor of PI3K

BQ-788 29A both po and iv applicationBQ788 is a endothelin B receptor antagonist. BQ788 attenuates stab wound injury induced reactive astrocytes in rat brain. BQ788 were well tolerated and showed signs of directly and indirectly reducing the viability of melanoma cells. Product information CAS Number: 173326 37 9 Molecular Weight: 641. 80 Formula: C34H51N5O7 Chemical Name: (2R) 2 [(2R) 2 [(2S) 2 {[(2R,6S) 2,6 dimethylpiperidine 1 carbonyl]amino} 4,4 dimethylpentanamido] 3 [1